AzTrials
AzTrials

Newborn DistressNCT01166880

A Pilot Study Using Laser Speckle Imaging of Neonate Cerebral Vasculature

An observational study of Newborn Distress, run by University of California, Irvine.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The researcher want to know whether reflections of light can be used to provide real-time pictures of blood vessel formation around infants' heads. This approach is called laser speckle imaging Read more about this study

Who is it for?
Ages 1 minute to 1 monthHealthy volunteers can take part
Conditions the study is for
Newborn Distress
What is being tested?
Laser Speckle Imaging
Type of treatment
Medical device
How many people
0 participants
Where
No sites listed yet
Study dates
Aug 2009to Sep 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 minute to 1 month
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: new born

Who may be able to join

  • newborn

Who cannot join

  • non-new bron

About this study

Official title: Imaging of Neonate Cerebral Vasculature

The researcher want to know whether reflections of light can be used to provide real-time pictures of blood vessel formation around infants' heads. This approach is called laser speckle imaging

Read the detailed description

This study involves imaging of superficial blood vessels in the infant's head. Analysis of reflected light images provides the type of data necessary to see the blood vessels.

The researcher want to assess only feasibility of our instrument. If we determine that our instrument has sufficient spatial resolution to image directly large vessels, then we will proceed with plans for a larger study with statistical power.

Being tested
Laser Speckle Imaging
Keywords
assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laser Speckle ImagingDevice

    Laser Speckle Imaging Infant Head Blood flow

Study groups in NCT01166880
Study groupRoleWhat they receive
Laser Speckle ImagingLaser Speckle Imaging Infant Head Blood flow
Receives: Device: Laser Speckle Imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neonate Cerebral Blood Flow

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2010 (estimated)
  2. Study startAug 2009
  3. Primary completionSep 2010
  4. Study completionSep 2010

Why it stopped: Unable to find grant fundingsupport to continue builds the study device.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01166880
Sponsor's protocol ID
20097050
Status last verified
Oct 2022
First submitted
20 Jul 2010
Last updated
1 Nov 2022
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Newborn Distress, run by University of California, Irvine.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 1 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neonate Cerebral Blood Flow (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in